These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29933048)

  • 21. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
    Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
    Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel target genes responsive to apoptotic activity by Ocimum gratissimum in human osteosarcoma cells.
    Lin CC; Chao PY; Shen CY; Shu JJ; Yen SK; Huang CY; Liu JY
    Am J Chin Med; 2014; 42(3):743-67. PubMed ID: 24871663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
    Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
    Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
    Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L
    Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
    Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
    Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin.
    He C; Sun J; Liu C; Jiang Y; Hao Y
    Clin Epigenetics; 2019 Jan; 11(1):8. PubMed ID: 30651137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
    He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
    Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
    Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
    Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
    Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
    Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
    Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
    Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
    Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
    Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
    Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
    Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
    Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
    Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.
    Vigneron AM; Ludwig RL; Vousden KH
    Genes Dev; 2010 Nov; 24(21):2430-9. PubMed ID: 21041411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.